ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Association of Donor-Derived Cell-Free DNA with Severity of Interstitial Fibrosis and Cortical Atrophy Lesions Following Kidney Transplantation

L. Bu1, E. Stites2, V. Bowers3, T. Alhamad4, J. S. Bromberg5, G. Gupta6, I. Moinuddin6, S. Ghosh7, W. Tian7, A. Pai8, S. Anand9

1University of Minnesota, Minneapolis, MN, 2University of Colorado, Aurora, CO, 3Tampa General Hospital, Tampa, FL, 4Washington University in St. Louis, St. Louis, MO, 5University of Maryland School of Medicine, Baltimore, MD, 6Virginia Commonwealth University, Richmond, VA, 7CareDx, Brisbane, CA, 8University of Texas McGovern Medical School, Houston, TX, 9Intermountain Medical Center, Murray, UT

Meeting: 2021 American Transplant Congress

Abstract number: 1062

Keywords: Histology, Kidney transplantation, Non-invasive diagnosis

Topic: Clinical Science » Kidney » Kidney Complications: Immune Mediated Late Graft Failure

Session Information

Session Name: Kidney Complications: Immune Mediated Late Graft Failure

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: The most common cause of kidney transplant (KT) failure is the poorly characterized histopathologic entity “interstitial fibrosis and tubular atrophy” (IFTA). There are no known unifying mechanisms, nor effective therapy, with diagnosis dependent on biopsy. Incidence of IFTA is ~50% at 1-yr post-KT, 70% at 2-yr, and nearly universal after 10-yr. The combination of IFTA with inflammation is associated with worsened prognosis than fibrosis alone. Considering the multifactorial pathogenesis of IFTA, the aggregation of mechanisms of injury using dd-cfDNA may allow surrogate quantification of inflammation.

*Methods: 299 patients with paired donor-derived cell-free DNA (dd-cfDNA, AlloSure®; CareDx.) and biopsy (Bx) visits were examined from the Assessing dd-cfDNA monitoring insights of renal allograft with longitudinal surveillance (ADMIRAL study; clinicaltrials.gov: NCT04566055219). Bx performed ≤ 20 days after the dd-cfDNA level, combination of “protocol” and clinical” for cause”. Pathology reports were centrally read and scored, and correlated with histology lesion and dd-cfDNA results. High dd-cfDNA was defined as >0.5% based on previous injury analysis based on ADMIRAL cohort. Interstitial fibrosis (ci) scores were grouped based on the Banff 2018 update. Ci(0)—Interstitial fibrosis in ≤5% of cortical area (normal), ci(1)—Interstitial fibrosis in 6-25% (mild), ci(2)—Interstitial fibrosis in 26-50% (moderate), ci(3)—Interstitial fibrosis in >50% of cortical area (severe).

*Results: dd-cfDNA was significantly elevated when Bx normal patients were compared to those mild to severe (ci). Mild: p= 0.006, moderate: p= 0.01, severe: p= 0.001

 border=

*Conclusions: The Banff Classification does not provide precise definition for individual areas of interstitial fibrosis. These results demonstrate a positive correlation between severity of IFTA and allograft injury assessed using dd-cfDNA. Consideration of dd-cfDNA levels with interpretation of histology, may be a useful adjunct in the assessment of interstitial fibrosis, as well as metrics to measure effectiveness of potential therapies.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bu L, Stites E, Bowers V, Alhamad T, Bromberg JS, Gupta G, Moinuddin I, Ghosh S, Tian W, Pai A, Anand S. Association of Donor-Derived Cell-Free DNA with Severity of Interstitial Fibrosis and Cortical Atrophy Lesions Following Kidney Transplantation [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/association-of-donor-derived-cell-free-dna-with-severity-of-interstitial-fibrosis-and-cortical-atrophy-lesions-following-kidney-transplantation/. Accessed May 9, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences